(Q30868193)

27 June 2017

1 reference

https://doi.org/10.1002/14651858.CD001042.pub2

1 reference

29 December 2023

http://retractionwatch.com/2010/09/20/progressive-how-the-cochrane-library-handles-updates-in-progress/

title

Cernilton for benign prostatic hyperplasia. (English)

1 reference

27 June 2017

prostatic hypertrophy

1 reference

T Wilt

1

1 reference

27 June 2017

R Mac Donald

2

1 reference

27 June 2017

A Ishani

3

1 reference

27 June 2017

I Rutks

4

1 reference

27 June 2017

G Stark

5

1 reference

27 June 2017

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

27 June 2017

1 reference

27 June 2017

2

1 reference

27 June 2017

CD001042

1 reference

Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study

27 June 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001042

The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001042

Benign prostatic hyperplasia. Medical and minimally invasive treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001042

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001042

Usefulness of Cernilton in the treatment of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001042

Clinical evaluation of long-term treatment using cernitin pollen extract in patients with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001042

Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001042

Some statistical methods for combining experimental results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001042

Inhibitory effect and synergism of cernitin pollen extract on the urethral smooth muscle and diaphragm of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001042

Micturition activity of pollen extract: contractile effects on bladder and inhibitory effects on urethral smooth muscle of mouse and pig

21 January 2018

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001042

The development of human benign prostatic hyperplasia with age

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001042

Benign Prostatic Hyperplasia: Antecedents and Natural History

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001042

A systematic review of Cernilton for the treatment of benign prostatic hyperplasia

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001042

Identifying relevant studies for systematic reviews

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001042

Identifiers

DOI

10.1002/14651858.CD001042

1 reference

27 June 2017

1 reference